(Q42475833)

1 November 2017

The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy (English)

1 reference

1 November 2017

1 reference

Hardman CD

1

1 reference

PubMed ID

10435500

1 November 2017

Halliday GM

series ordinal

2

1 reference

PubMed ID

10435500

1 November 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

1 November 2017

1 reference

1 November 2017

14

1 reference

1 November 2017

4

1 reference

1 November 2017

626-633

1 reference

An autoradiographic study of efferent connections of the globus pallidus in Macaca mulatta.

1 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The organization of the descending ventral pallidal projections in the monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Functional and pathophysiological models of the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Updating the functional model of the basal ganglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The current model of basal ganglia organization under scrutiny

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Neuropathological problems posed by carbon monoxide poisoning and anoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The behavioural and motor consequences of focal lesions of the basal ganglia in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Pallidal lesions. Structural and functional magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The distribution of enkephalin immunoreactive fibers and terminals in the monkey central nervous system: an immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Calbindin D-28k and parvalbumin in the rat nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Complementary Distribution of Calbindin D-28k and Parvalbumin in the Basal Forebrain and Midbrain of the Squirrel Monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Calcium buffering properties of calbindin D28k and parvalbumin in rat sensory neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Differing influences of dopamine agonists and antagonists on Fos expression in identified populations of globus pallidus neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Substantia nigra pars reticulata neurons in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Staging of Alzheimer's disease-related neurofibrillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

A consideration of neural counting methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Are you using neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Alterations of GABAergic neurons in the basal ganglia of patients with progressive supranuclear palsy: an in situ hybridization study of GAD67 messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Opposite motor effects of pallidal stimulation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Posteroventral pallidotomy in a patient with parkinsonism caused by hypoxic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Emerging treatments in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Interconnections and organization of pallidal and subthalamic nucleus neurons in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The role of the subthalamic nucleus in experimental chorea. Evidence from 2-deoxyglucose metabolic mapping and horseradish peroxidase tracing studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Correlation between met-enkephalin and substance P immunoreactivity in the primate globus pallidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Fast spiking cells in rat hippocampus (CA1 region) contain the calcium-binding protein parvalbumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Glial inclusions in CNS degenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

The neuropathology of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

GLOBUS PALLIDUS IN PARKINSONISM

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Ontogeny of the calcium binding protein parvalbumin in the rat nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Selective decrease of large neurons in the neostriatum in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

Bilateral subthalamic nucleus stimulation for severe Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199907%2914%3A4%3C626%3A%3AAID-MDS1012%3E3.0.CO%3B2-U

10.1002/1531-8257(199907)14:4<626::AID-MDS1012>3.0.CO;2-U

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference

PubMed ID

10435500